İçeriğe geç
SON HABERLER
BirdsEyeView ve JBA Risk Management, Küresel Sel Risk Haritalarını CERA Platformuna Entegre EttiMunich Re ve Generation Life, Avustralya’da Emeklilik Gelirine Beş Yıla Kadar Güvence Sunan Özelliği BaşlattıKorean Re’nin 2026 İlk Dokuz Aylık Net Kârı Yüzde 48,9 Artarak 401,6 Milyar Wona UlaştıGenerali, 2027 Hedeflerini Aşmayı Bekliyor: Yapay Zekâdan 200 Milyon Avroyu Aşan Katkı ÖngörüsüLegal & General’ın 2026 Üçüncü Çeyrek Sonuçları: Sermaye Yeterlilik Oranı Yüzde 213’e UlaştıHong Kong’un İlk Yerel P&I Kulübü Faaliyete Başladı: İlk Poliçe OOCL Grace GemisineAon, USI Insurance Services Satın Alımını 17 Milyar Dolara TamamladıAvustralya’da Şiddetli Fırtınalar Sonrası Sigorta Hasar Başvuruları 9 Bini AştıSwiss Re, 2027 ve 2028 İçin Küresel Sigorta Prim Büyüme Tahminlerini AçıkladıKamil Dilek: “Sigortacılıkta Esas Dönüşüm, İş Süreçlerini Yapay Zekâya Göre Yeniden Tasarlamakla Başlıyor”Zurich UK, Üç Yardım Kuruluşuna 100 Saatlik Uzmanlık Desteği Programını DuyurduZurich, Beazley Birleşmesinde Sermaye Sinerjisi Beklentisini 1,8 Milyar Dolara YükselttiZurich, İngiltere ve Avustralya Hayat Sigortası Pazar Paylarını AçıkladıBNP Paribas Cardif, Almanya’da Yeni Emeklilik Hesabına İşsizlik ve İş Göremezlik Teminatı SağlayacakBNP Paribas Cardif’in Fransa’daki Dayanışma Finansmanı Programında ADIE’ye 20 Bin Avro DestekBNP Paribas Cardif Peru, Ekim 2026 Mali Tablolarını Açıkladı: Net Kâr 42,8 Milyon SolSompo Japan, Narita Havalimanı’ndaki Otonom Satış Robotlarına Sorumluluk Sigortası Sunmaya BaşladıSompo Holdings ve NTT, Yaşlı Bakımında Fiziksel Yapay Zekâ Uygulamaları İçin AnlaştıSompo Japan, Uluslararası Deniz Yük Sigortasında Zarar Önleme Masraflarını Teminata AldıFitch, MAPFRE’nin İhraççı Kredi Notunu A+’ya Yükseltti
English

Pioneering CRISPR Gene Therapy Saves Infant with Rare Genetic Disorder

Discover how groundbreaking CRISPR gene therapy successfully treated an infant with a rare genetic disorder, marking a new era in medicine.

Bağlantı kopyalandı!
Pioneering CRISPR Gene Therapy Saves Infant with Rare Genetic Disorder
Pioneering CRISPR Gene Therapy Saves Infant with Rare Genetic Disorder

A Historic Breakthrough in Genetic Science

A team of specialists at the Children‘s Hospital of Philadelphia (CHOP) and Penn Medicine have achieved a groundbreaking success by treating an infant diagnosed with a rare genetic condition through a specially tailored CRISPR-based gene editing therapy. Baby KJ was born with the genetic anomaly known as carbamoyl phosphate synthase 1 (CPS1) deficiency, a disorder that hinders the body’s ability to metabolize nitrogen efficiently, resulting in hazardous ammonia accumulation within the bloodstream. Initially confined to a hospital environment and placed on a severely restricted diet, KJ received his pioneering treatment in February 2025 at the age of six to seven months. The therapy was administered without complications, and KJ is now showing healthy growth.

A Historic Breakthrough in Genetic Science

The Inaugural Custom CRISPR Gene Editing Therapy

This innovative treatment marks the world’s first completely customized CRISPR gene editing therapy. This milestone is significant as it illustrates the potential of gene editing technology to effectively target and correct genetic abnormalities in patients lacking existing treatment options for rare genetic disorders. CRISPR technology, renowned for its precision, enables the alteration of specific genetic sequences in the human genome. While this technology has been applied to more prevalent conditions such as sickle cell disease and beta-thalassemia, with FDA-approved therapies already available, many individuals with rare genetic diseases have not been able to benefit from these advancements due to the unique nature of their genetic variations.

In 2023, Dr. Ahrens-Nicklas and Dr. Kiran Musunuru from Penn University initiated a collaborative effort to investigate the feasibility of personalized gene editing therapies. Both researchers are part of the NIH-funded Somatic Cell Genome Editing Consortium and have devoted their careers to studying rare metabolic diseases. Their research focused on urea cycle disorders, which prevent the elimination of ammonia—a byproduct of protein breakdown. In these disorders, the liver lacks the enzymes necessary to convert ammonia into urea, leading to potential damage to the brain and liver.

Encouraging Results

KJ’s genetic disorder was identified shortly after his birth, prompting the research team to develop a mutation-specific treatment within a mere six months. They crafted a base-editing therapy that was delivered to the liver using lipid nanoparticles. KJ received his initial infusion in late February 2025, followed by two additional doses in March and April, all without experiencing any severe side effects. He soon began consuming protein-rich foods and tolerated them well, also managing to recover from common childhood illnesses, such as rhinovirus, without an ammonia spike in his system. While further monitoring is essential to understand the long-term impact, the preliminary results are promising.

Dr. Ahrens-Nicklas expressed optimism about the pioneering therapy, stating, “Although KJ will require lifelong monitoring, our initial outcomes are highly encouraging.” Dr. Musunuru added, “We aspire for every patient to achieve the positive outcomes witnessed in this inaugural patient. We hope other academic researchers will adopt this approach for numerous rare diseases, providing countless patients the opportunity for a healthy life.” “The long-awaited promise of gene therapy is becoming a reality, fundamentally transforming our approach to medicine.”

Benzer Haberler

Tümü
Phone showing a generic verification symbol next to laptop, UK insurance company FCA authorisation check concept
How to Verify a UK Insurance Company in 2026: FCA Firm Checker, Register and FSCS Guide
JD Vance Leads Early Contest to Succeed Trump as Marco Rubio Emerges as Main Alternative for 2028
JD Vance Leads Early Contest to Succeed Trump as Marco Rubio Emerges as Main Alternative for 2028
WHO Raises Ebola Public Health Risk to Very High in DR Congo as Cases Increase
WHO Raises Ebola Public Health Risk to Very High in DR Congo as Cases Increase
Pakistan Army Chief Visits Tehran as US-Iran Talks Show Limited Progress
Pakistan Army Chief Visits Tehran as US-Iran Talks Show Limited Progress
Xi Orders Full Rescue Response After Coal Mine Gas Explosion in Northern China Kills Over 80
Xi Orders Full Rescue Response After Coal Mine Gas Explosion in Northern China Kills Over 80
Italy expands defence cooperation with Kuwait through Leonardo naval systems, air force support, and regional military presence
Italy expands defence cooperation with Kuwait through Leonardo naval systems, air force support, and regional military presence
SİGORTA HABER YAYIN AĞI • İçerikler 5 dakikada bir yenilenirBağlantı dizini
En Güncel ve Doğru Haberler!

Sigorta Haber, sigorta sektöründeki en güncel haberleri, analizleri ve gelişmeleri tarafsız bir bakış açısıyla sunan bağımsız bir haber platformudur. Sigorta profesyonellerine, acentelere ve sektöre ilgi duyan herkese doğru, hızlı ve güvenilir bilgi sağlamayı amaçlıyoruz. Sigortacılıktaki yenilikleri, mevzuat değişikliklerini ve sektör trendlerini yakından takip ederek, okuyucularımıza kapsamlı bir bilgi kaynağı sunuyoruz.

2026 Sigorta Haber © Tüm hakları saklıdır.